91 – 100 of 557
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Re : Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
Salvage radiotherapy after radical prostatectomy : functional outcomes in the LAPPRO trial after 8-year follow-up
- Contribution to journal › Article
-
Mark
Men's Perception of Being Invited for Prostate Cancer Testing and the Information About Its Pros and Cons—A Survey from Two Population-based Testing Programmes
- Contribution to journal › Article
-
Mark
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
- Contribution to journal › Article
-
Mark
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management
- Contribution to journal › Article
-
Mark
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
- Contribution to journal › Article
-
Mark
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022 : The Urologist's Point of View
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of phoenixin in the proliferation and migration of ectopic epithelial cells in vitro
- Contribution to journal › Article
-
Mark
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
- Contribution to journal › Scientific review
